Crossmark

Meropenem-vaborbactam as intrathecal-sparing therapy for the treatment of carbapenem-resistant K. pneumoniae shunt-related ventriculitis: two case reports and review of the literature

Crossref DOI link: https://doi.org/10.1007/s10096-024-04986-6

Published Online: 2024-11-12

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Giuliano, Gabriele

Sambo, Margherita

Castellani, Paola

Benedetti, Sara

Tarantino, Francesca

Tumbarello, Mario
License Information

Text and Data Mining valid from 2024-11-12

Version of Record valid from 2024-11-12
More Information

Article History

Received: 15 September 2024

Accepted: 4 November 2024

First Online: 12 November 2024

Declarations

:

: Clinical practices described have been approved by the Regional Ethics Committee for Clinical Trials of the Tuscany Region (Section: Area Vasta Sud-Est) with protocol number 26582.

: The authors declare no competing interests.

: The authors declare that they have no conflicts of interest.

Document is current

Any future updates will be listed below